You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 2, February 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Interferon in Biopsy and Autopsy Specimens of Brain

Its Presence in Herpes Simplex Virus Encephalitis

Ruben C. Legaspi, MD; Bienvenido Gatmaitan, MD; Elizabeth J. Bailey, BS, MT (ASCP); A. Martin Lerner, MD

Arch Neurol. 1980;37(2):76-79.


Abstract

• Quantitative virus and interferon titers were assayed in temporal lobe brain biopsy specimens (six patients); in various regions of the brain at autopsy (five of the six patients); and in serums and CSF during courses of herpes simplex virus, type 1 (HSV-1) encephalitis. Until the tenth day of neurologic disease, interferon (geometric mean titer, 25 units/mL) was present in each virus-positive brain biopsy specimen. The geometric mean HSV-1 titer at brain biopsy was 328 tissue culture dose (TCD)50/g. On the sixth day of disease, CSF from the sole survivor contained 160 units/mL, but five other samples of CSF contained no detectable interferon. No serums from any of the six patients contained interferon. At autopsies performed on the sixth to 19th day of neurologic disease, 13 of 35 of the regional areas of the brain retained HSV, but only a single specimen from a temporal lobe had measurable interferon. Early in the course of HSV-1 encephalitis, substantial interferon titers are present in areas of virus multiplication. This local brain interferon is insufficient alone to inhibit progression of disease but could possibly be important in combination with antiviral chemotherapy.



Author Affiliations

From the Hutzel Hospital Medical Unit, Department of Medicine (Drs Lerner, Gatmaitan, and Legaspi and Ms Bailey), Wayne State University School of Medicine, Detroit, and the Veterans Administration Medical Center (Drs Gatmaitan and Legaspi), Allen Park, Mich. Dr Legaspi is now in private practice in Roseville, Mich.


Footnotes

Accepted for publication April 13, 1979.

Reprint requests to Hutzel Hospital, 4707 St Antoine Blvd, Detroit, MI 48201 (Dr Lerner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.